Renal catabolism of advanced glycation end products: The fate of pentosidine

Kidney International

Volumn 53, Issue 2, 1998, Pages 416-422

  Miyata, Toshio ^a   Ueda, Yasuhiko ^b   Horie, Katsunori ^b   Nangaku, Masaomi ^b   Tanaka, Shuichi ^b   Van Ypersele De Strihou, Charles ^b   Kurokawa, Kiyoshi ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Advanced glycation end products; Pentosidine; Protein; Tissue injury

Indexed keywords

GENTAMICIN; GLYCOSYLATED PROTEIN; PENTOSIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GLOMERULUS FILTRATION; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; URINARY EXCRETION;

EID: 0031930853     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00756.x     Document Type: Article

References (25)

1. BROWNLEE M, CERAMI A, VLASSARA H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
2. VLASSARA H, BROWNLEE M, MANOGUE KR, DINARELLO CA, PASAGIAN A: Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science 240:1546-1548, 1988
3. MIYATA T, INAGI R, IIDA Y, SATO M, YAMADA N, OSA O, MAEDA K, SEO H: Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin 1. J Clin Invest 93:521-528, 1994
4. IIDA Y, MIYATA T, INAGI R, SUGIYAMA S, MAEDA K: β2-Microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: Role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem Biophys Res Commun 201: 1235-1241, 1994
5. MIYATA T, IIDA Y, UEDA Y, SHINZATO T, SEO H, MONNIER VM, MAEDA K: Monocyte/macrophage response to β2-microglobulin modified with the advanced glycation end products. Kidney Int 49:538-550, 1996
6. MIYATA T, NOTOYA K, YOSHIDA K, HORIE K, KUROKAWA K, MAEDA K, TAKETOMI S: Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 8:260-270, 1997
7. NEEPER M, SCHMIDT AM, BRETT J, YAN SD, WANG F, PAN YC, ELLISTON K, STERN D, SHAW A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004, 1992
8. SCHMIDT AM, YON SD, BRETT J, MORA R, NOWYGROD R, STERN D: Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 92:2155-2168, 1993
9. MIYATA T, HORI O, ZHANG JH, YAN SD, FERRAN L, IIDA Y, SCHMIDT AM: The receptor for advanced glycation endproducts mediates the interaction of AGE-β2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: Implication for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 98:1088-1094, 1996
10. BAYNES JW: Perspectives in diabetes. Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
11. YAN SD, SCHMIDT AM, ANDERSON GM, ZHANG J, BRETT J, ZOU YS, PINSKY D, STERN D: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269:9889-9897, 1994
12. DYER DG, DUNN JA, THORPE SR, BAILIE KE, LYONS TJ, MCCANCE DR, BAYNES JW: Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91:2463-2469, 1993
13. BEISSWENGER PJ, MOORE LL, BRINK-JOHNSEN T: Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92:212-217, 1993
14. ODETTI P, FORGARTY J, SELL DR, MONNIER VM: Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 41:153-159, 1992
15. MIYATA T, UEDA Y, SHINZATO T, IIDA Y, TANAKA S, KUROKAWA K, VAN YPERSELE DE STRIHOU C, MAEDA K: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7:1198-1206, 1996
16. MIYATA T, UEDA Y, YOSHIDA A, SUGIYAMA S, IIDA Y, JODAUL M, MAEDA K, KUROKAWA K, VAN YPERSELE DE STRIHOU C: Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy. Kidney Int 51:880-887, 1997
17. ∈-lysino)-lactic acid from model compounds and glycated proteins. J Biol Chem 263:8816-8821, 1988
18. WELLS-KNECHT KJ, ZYZAK DV, LITCHFIELD JE, THORPE SR, BAYNES JW: Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autoxidative modification of protein by glucose. Biochemistry 34:3702-3709, 1995
19. SELL DR, MONNIER VM: Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 264:21597-21602, 1989
20. ∈-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261:4889-4894, 1986
21. MAKITA Z, RADOFF S, RAYFIELD EJ, YANG Z, SKOLNIK E, DELANEY V, FRIEDMAN EA: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842, 1991
22. MIYATA T, TANEDA S, KAWAI R, UEDA Y, HORIUCHI S, HARA M, MAEDA K, MONNIER VM: Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 93:2353-2358, 1996
23. OLBRICHT CJ, FINK M, GUTJAHRE E: Alterations in lysosomal enzymes of the proximal tubule in gentamicin nephrotoxicity. Kidney Int 39:639-646, 1991
24. BENDAYAN M, LONDONO I: Reabsorption of native and glycated albumin by renal proximal tubular epithelial cells. Am J Physiol 40:F261-F268, 1996
25. GUGLIUCCI A, BANDAYAN M: Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 39:149-160, 1996